Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-Binding
暂无分享,去创建一个
E. van Marck | A. Harris | P. V. van Dam | J. Weyler | G. G. Van den Eynden | I. Van der Auwera | P. Vermeulen | L. Dirix | S. V. van Laere | H. Elst
[1] E. van Marck,et al. Tumor Lymphangiogenesis in Inflammatory Breast Carcinoma: A Histomorphometric Study , 2005, Clinical Cancer Research.
[2] Luc Y. Dirix,et al. Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis , 2005, Breast Cancer Research and Treatment.
[3] Urs Eppenberger,et al. Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers , 2005 .
[4] D. Kalaitzidis,et al. Transcription factor cross-talk: the estrogen receptor and NF-κB , 2005, Trends in Endocrinology & Metabolism.
[5] I. Bièche,et al. Update on inflammatory breast cancer , 2005, Breast Cancer Research.
[6] R. Dumitrescu,et al. Understanding breast cancer risk ‐ where do we stand in 2005? , 2005, Journal of cellular and molecular medicine.
[7] Luc Y Dirix,et al. Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression Quantification , 2004, Clinical Cancer Research.
[8] S. Steinberg,et al. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] D. Chalbos,et al. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells , 2004, Oncogene.
[10] S. Merajver,et al. Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer , 2004, Breast Cancer Research and Treatment.
[11] V. Jordan,et al. Selective estrogen receptor modulation: concept and consequences in cancer. , 2004, Cancer cell.
[12] S. Merajver,et al. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer , 2003, Breast Cancer Research.
[13] David Baltimore,et al. Genetic analysis of NF‐κB/Rel transcription factors defines functional specificities , 2003, The EMBO journal.
[14] Robert Clarke,et al. Estrogen Withdrawal-Induced NF-κB Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone Independence , 2003, Molecular and Cellular Biology.
[15] K. V. van Golen. Inflammatory breast cancer: Relationship between growth factor signaling and motility in aggressive cancers , 2003, Breast Cancer Research.
[16] E. van Marck,et al. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression , 2003, British Journal of Cancer.
[17] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[19] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[20] A. Pardee,et al. The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Merajver,et al. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. , 2000, Neoplasia.
[22] Debajit K. Biswas,et al. Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells , 2000 .
[23] S. Merajver,et al. Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants , 2000, Breast Cancer Research.
[24] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[25] S. Merajver,et al. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] G. Sledge,et al. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.
[27] B Stein,et al. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.
[28] K. Ebeling,et al. [Epidemiology of breast cancer]. , 1988, Archiv fur Geschwulstforschung.
[29] F. Rosato,et al. Diseases of the Breast , 1972 .
[30] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .